{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:28:28Z","timestamp":1773908908359,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11739-024-03669-6","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T08:01:34Z","timestamp":1717833694000},"page":"1675-1685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5789-3813","authenticated-orcid":false,"given":"Luigi","family":"Gatta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-857X","authenticated-orcid":false,"given":"Carmelo","family":"Scarpignato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Marrocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Chiriatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Lambiase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Usai-Satta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Monica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Manta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvestro","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Soncini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Federation of General Practitioners (FIMMG)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,8]]},"reference":[{"issue":"6","key":"3669_CR1","first-page":"541","volume":"32","author":"A Zullo","year":"2019","unstructured":"Zullo A, Gatta L, Vassallo R, Francesco V, Manta R, Monica F et al (2019) Paradigm shift: the Copernican revolution in diverticular disease. Ann Gastroenterol 32(6):541\u2013553","journal-title":"Ann Gastroenterol"},{"issue":"1","key":"3669_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-020-0153-5","volume":"6","author":"A Tursi","year":"2020","unstructured":"Tursi A, Scarpignato C, Strate LL, Lanas A, Kruis W, Lahat A et al (2020) Colonic diverticular disease. Nat Rev Dis Primers 6(1):20","journal-title":"Nat Rev Dis Primers"},{"issue":"suppl. 4","key":"3669_CR3","first-page":"57","volume":"28","author":"A Tursi","year":"2019","unstructured":"Tursi A, Brandimarte G, Di Mario F, Lanas A, Scarpignato C, Bafutto M et al (2019) International consensus on diverticulosis and diverticular disease: statements from the 3rd international symposium on diverticular disease. J Gastrointest Liver Dis 28(suppl. 4):57\u201366","journal-title":"J Gastrointest Liver Dis"},{"issue":"6","key":"3669_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.dld.2017.01.164","volume":"49","author":"R Cuomo","year":"2017","unstructured":"Cuomo R, Barbara G, Annibale B (2017) Rifaximin and diverticular disease: position paper of the Italian Society of Gastroenterology (SIGE). Dig Liv Dis 49(6):595\u2013603","journal-title":"Dig Liv Dis"},{"key":"3669_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n72","volume":"372","author":"AF Peery","year":"2021","unstructured":"Peery AF (2021) Management of colonic diverticulitis. BMJ 372:n72","journal-title":"BMJ"},{"issue":"11","key":"3669_CR6","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/ajg.2015.302","volume":"110","author":"AE Bharucha","year":"2015","unstructured":"Bharucha AE, Parthasarathy G, Ditah I, Fletcher JG, Ewelukwa O, Pendlimari R et al (2015) Temporal trends in the incidence and natural history of diverticulitis: a population-based study. Am J Gastroenterol 110(11):1589\u20131596","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"3669_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10151-018-1840-z","volume":"22","author":"GA Binda","year":"2018","unstructured":"Binda GA, Mataloni F, Bruzzone M, Carabotti M, Cirocchi R, Nascimbeni R et al (2018) Trends in hospital admission for acute diverticulitis in Italy from 2008 to 2015. Tech Coloproctol 22(8):597\u2013604","journal-title":"Tech Coloproctol"},{"issue":"2","key":"3669_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000492178","volume":"3","author":"H Imaeda","year":"2018","unstructured":"Imaeda H, Hibi T (2018) The burden of diverticular disease and its complications: west versus east. Inflamm Intest Dis 3(2):61\u201368","journal-title":"Inflamm Intest Dis"},{"issue":"1","key":"3669_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","volume":"156","author":"AF Peery","year":"2019","unstructured":"Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL et al (2019) Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 156(1):254-272.e211","journal-title":"Gastroenterology"},{"issue":"1","key":"3669_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11739-023-03446-x","volume":"19","author":"G Santacroce","year":"2024","unstructured":"Santacroce G, Lenti MV, Abruzzese GM, Alunno G, Di Terlizzi F, Frenna C et al (2024) Diagnostic delay in symptomatic uncomplicated diverticular disease: an Italian tertiary referral centre study. Intern Emerg Med 19(1):99\u2013106","journal-title":"Intern Emerg Med"},{"issue":"5","key":"3669_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/2050640614547068","volume":"2","author":"R Cuomo","year":"2014","unstructured":"Cuomo R, Barbara G, Pace F, Annese V, Bassotti G, Binda GA et al (2014) Italian consensus conference for colonic diverticulosis and diverticular disease. United Eur Gastroenterol J 2(5):413\u2013442","journal-title":"United Eur Gastroenterol J"},{"issue":"10","key":"3669_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10151-015-1370-x","volume":"19","author":"GA Binda","year":"2015","unstructured":"Binda GA, Cuomo R, Laghi A, Nascimbeni R, Serventi A, Bellini D et al (2015) Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines. Tech Coloproctol 19(10):615\u2013626","journal-title":"Tech Coloproctol"},{"issue":"4","key":"3669_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/ajg.2016.41","volume":"111","author":"LL Strate","year":"2016","unstructured":"Strate LL, Gralnek IM (2016) ACG clinical guideline: management of patients with acute lower gastrointestinal bleeding. Am J Gastroenterol 111(4):459\u2013474","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"3669_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/codi.15140","volume":"22","author":"JK Schultz","year":"2020","unstructured":"Schultz JK, Azhar N, Binda GA, Barbara G, Biondo S, Boermeester MA et al (2020) European Society of Coloproctology: guidelines for the management of diverticular disease of the colon. Colorectal Dis 22(Suppl 2):5\u201328","journal-title":"Colorectal Dis"},{"issue":"3","key":"3669_CR15","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1053\/j.gastro.2020.09.059","volume":"160","author":"AF Peery","year":"2021","unstructured":"Peery AF, Shaukat A, Strate LL (2021) AGA clinical practice update on medical management of colonic diverticulitis: expert review. Gastroenterology 160(3):906-911.e901","journal-title":"Gastroenterology"},{"issue":"suppl. 1","key":"3669_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000081990","volume":"51","author":"C Scarpignato","year":"2005","unstructured":"Scarpignato C, Pelosini I (2005) Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential. Chemotherapy 51(suppl. 1):36\u201366","journal-title":"Chemotherapy"},{"issue":"3","key":"3669_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/antibiotics12030443","volume":"12","author":"A Piccin","year":"2023","unstructured":"Piccin A, Gulotta M, di Bella S, Martingano P, Croce LS, Giuffre M (2023) Diverticular disease and rifaximin: an evidence-based review. Antibiotics (Basel) 12(3):443","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"3669_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apt.13928","volume":"45","author":"L Gatta","year":"2017","unstructured":"Gatta L, Scarpignato C (2017) Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther 45(5):604\u2013616","journal-title":"Aliment Pharmacol Ther"},{"key":"3669_CR19","volume-title":"Statistics with confidence","author":"RG Newcombe","year":"2000","unstructured":"Newcombe RG, Altman DG (2000) Proportions and their difference. In: Altman DG, Machin D, Bryant T, Gardner M (eds) Statistics with confidence, 2nd edn. BMJ Books, London","edition":"2"},{"key":"3669_CR20","volume-title":"SpringerLink: Logistic regression: a self-learning text","author":"DG Kleinbaum","year":"2010","unstructured":"Kleinbaum DG, Klein M (2010) SpringerLink: Logistic regression: a self-learning text. Springer, New York, New York, NY"},{"issue":"9","key":"3669_CR21","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1046\/j.1365-2036.2003.01551.x","volume":"17","author":"JY Kang","year":"2003","unstructured":"Kang JY, Hoare J, Tinto A, Subramanian S, Ellis C, Majeed A et al (2003) Diverticular disease of the colon: on the rise\u2014a study of hospital admissions in England between 1989\/1990 and 1999\/2000. Aliment Pharmacol Ther 17(9):1189\u20131195","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"3669_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/codi.12811","volume":"17","author":"HM Paterson","year":"2015","unstructured":"Paterson HM, Arnott ID, Nicholls RJ, Clark D, Bauer J, Bridger PC et al (2015) Diverticular disease in Scotland: 2000\u20132010. Colorectal Dis 17(4):329\u2013334","journal-title":"Colorectal Dis"},{"issue":"11\u201312","key":"3669_CR23","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1365-2036.2009.04098.x","volume":"30","author":"S Jeyarajah","year":"2009","unstructured":"Jeyarajah S, Faiz O, Bottle A, Aylin P, Bjarnason I, Tekkis PP et al (2009) Diverticular disease hospital admissions are increasing, with poor outcomes in the elderly and emergency admissions. Aliment Pharmacol Ther 30(11\u201312):1171\u20131182","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"3669_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10151-020-02150-8","volume":"24","author":"A Amato","year":"2020","unstructured":"Amato A, Mataloni F, Bruzzone M, Carabotti M, Cirocchi R, Nascimbeni R et al (2020) Hospital admission for complicated diverticulitis is increasing in Italy, especially in younger patients: a national database study. Tech Coloproctol 24(3):237\u2013245","journal-title":"Tech Coloproctol"},{"issue":"6","key":"3669_CR25","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/bjs5.50336","volume":"4","author":"BT Alexandersson","year":"2020","unstructured":"Alexandersson BT, Stefansson T (2020) Incidence and recurrence rate of sigmoid diverticulitis in patients requiring admission to hospital in Iceland from 1985 to 2014: nationwide population-based register study. BJS Open 4(6):1217\u20131226","journal-title":"BJS Open"},{"issue":"1","key":"3669_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000335721","volume":"30","author":"R Spiller","year":"2012","unstructured":"Spiller R (2012) Is it diverticular disease or is it irritable bowel syndrome? Dig Dis 30(1):64\u201369","journal-title":"Dig Dis"},{"issue":"1","key":"3669_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/MOG.0000000000000499","volume":"35","author":"RZ Alamo","year":"2019","unstructured":"Alamo RZ, Quigley EMM (2019) Irritable bowel syndrome and colonic diverticular disease: overlapping symptoms and overlapping therapeutic approaches. Curr Opin Gastroenterol 35(1):27\u201333","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"3669_CR28","first-page":"C4453","volume":"59","author":"JC Andersen","year":"2012","unstructured":"Andersen JC, Bundgaard L, Elbr\u00f8nd H, Laurberg S, Walker LR, St\u00f8vring J (2012) Danish national guidelines for treatment of diverticular disease. Dan Med J 59(5):C4453","journal-title":"Dan Med J"},{"issue":"4","key":"3669_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1515\/pjs-2015-0045","volume":"87","author":"A Pietrzak","year":"2015","unstructured":"Pietrzak A, Bartnik W, Szczepkowski M, K rokowicz P, Dziki A, Regul\u0142a J, et al (2015) Polish interdisciplinary consensus on diagnostics and treatment of colonic diverticulosis (2015). Pol Przegl Chir 87(4):203\u2013220","journal-title":"Pol Przegl Chir"},{"issue":"4","key":"3669_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.15403\/jgld.2014.1121.274.rom","volume":"27","author":"A Trifan","year":"2018","unstructured":"Trifan A, Gheorghe C, Sabo CM, Diculescu M, Nedelcu L, Singeap AM et al (2018) Diagnosis and treatment of colonic diverticular disease: position paper of the Romanian society of gastroenterology and hepatology. J Gastrointest Liver Dis 27(4):449\u2013457","journal-title":"J Gastrointest Liver Dis"},{"issue":"2","key":"3669_CR31","first-page":"220","volume":"84","author":"R Ra\u00f1a-Garibay","year":"2019","unstructured":"Ra\u00f1a-Garibay R, Salgado-Nesme N, Carmona-S\u00e1nchez R, Remes-Troche JM, Aguilera-Carrera J, Alonso-S\u00e1nchez L et al (2019) The Mexican consensus on the diagnosis and treatment of diverticular disease of the colon. Rev Gastroenterol Mex (Eng Ed) 84(2):220\u2013240","journal-title":"Rev Gastroenterol Mex (Eng Ed)"},{"key":"3669_CR32","unstructured":"National Institute for Health and Care Excellence (NICE) (2019) Diverticular disease: diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/ng147"},{"issue":"9","key":"3669_CR33","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ueg2.12313","volume":"10","author":"W Kruis","year":"2022","unstructured":"Kruis W, Germer CT, Bohm S, Dumoulin FL, Frieling T, Hampe J et al (2022) German guideline diverticular disease\/diverticulitis: part II\u2014conservative, interventional and surgical management. United Eur Gastroenterol J 10(9):940\u2013957","journal-title":"United Eur Gastroenterol J"},{"issue":"3","key":"3669_CR34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/gut.33.3.352","volume":"33","author":"HA Thorburn","year":"1992","unstructured":"Thorburn HA, Carter KB, Goldberg JA, Finlay IG (1992) Does ispaghula husk stimulate the entire colon in diverticular disease? Gut 33(3):352\u2013356","journal-title":"Gut"},{"issue":"8","key":"3669_CR35","first-page":"452","volume":"24","author":"C Papi","year":"1992","unstructured":"Papi C, Ciaco A, Koch M, Capurso L (1992) Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon: a pilot multicentre open trial\u2014diverticular disease study group. Ital J Gastroenterol 24(8):452\u2013456","journal-title":"Ital J Gastroenterol"},{"issue":"1","key":"3669_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2036.1995.tb00348.x","volume":"9","author":"C Papi","year":"1995","unstructured":"Papi C, Ciaco A, Koch M, Capurso L (1995) Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon: a multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 9(1):33\u201339","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3669_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00384-002-0396-5","volume":"18","author":"G Latella","year":"2003","unstructured":"Latella G, Pimpo MT, Sottili S, Zippi M, Viscido A, Chiaramonte M et al (2003) Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 18(1):55\u201362","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"3669_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.dld.2012.09.006","volume":"45","author":"A Lanas","year":"2013","unstructured":"Lanas A, Ponce J, Bignamini A, Mearin F (2013) One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study. Dig Liver Dis 45(2):104\u2013109","journal-title":"Dig Liver Dis"},{"issue":"6","key":"3669_CR39","first-page":"1397","volume":"21","author":"V Festa","year":"2017","unstructured":"Festa V, Spila Alegiani S, Chiesara F, Moretti A, Bianchi M, Dezi A et al (2017) Retrospective comparison of long-term 10-day\/month rifaximin or mesalazine in prevention of relapse in acute diverticulitis. Eur Rev Med Pharmacol Sci 21(6):1397\u20131404","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"3669_CR40","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S1590-8658(02)80110-4","volume":"34","author":"A Tursi","year":"2002","unstructured":"Tursi A, Brandimarte G, Daffin\u00e0 R (2002) Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 34(7):510\u2013515","journal-title":"Dig Liver Dis"},{"issue":"5","key":"3669_CR41","first-page":"Pi70","volume":"10","author":"G Brandimarte","year":"2004","unstructured":"Brandimarte G, Tursi A (2004) Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease. Med Sci Monit 10(5):Pi70-73","journal-title":"Med Sci Monit"},{"issue":"12","key":"3669_CR42","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.cgh.2013.03.007","volume":"11","author":"E Cohen","year":"2013","unstructured":"Cohen E, Fuller G, Bolus R, Modi R, Vu M, Shahedi K et al (2013) Increased risk for irritable bowel syndrome after acute diverticulitis. Clin Gastroenterol Hepatol 11(12):1614\u20131619","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"3669_CR43","doi-asserted-by":"publisher","first-page":"E178","DOI":"10.1097\/MCG.0000000000000980","volume":"53","author":"A Lahat","year":"2019","unstructured":"Lahat A, Necula D, Yavzori M, Picard O, Halperin S, Eliakim R et al (2019) Prolonged recurrent abdominal pain is associated with ongoing underlying mucosal inflammation in patients who had an episode of acute complicated diverticulitis. J Clin Gastroenterol 53(5):E178\u2013E185","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"3669_CR44","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1053\/j.gastro.2018.12.033","volume":"156","author":"LL Strate","year":"2019","unstructured":"Strate LL, Morris AM (2019) Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology 156(5):1282\u20131298","journal-title":"Gastroenterology"},{"issue":"12","key":"3669_CR45","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.cgh.2013.06.020","volume":"11","author":"K Shahedi","year":"2013","unstructured":"Shahedi K, Fuller G, Bolus R, Cohen E, Vu M, Shah R et al (2013) Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy. Clin Gastroenterol Hepatol 11(12):1609\u20131613","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3669_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.clnesp.2020.12.025","volume":"42","author":"F Di Pierro","year":"2021","unstructured":"Di Pierro F, Pane M (2021) Bifidobacterium longum W11: uniqueness and individual or combined clinical use in association with rifaximin. Clin Nutr ESPEN 42:15\u201321","journal-title":"Clin Nutr ESPEN"},{"issue":"Suppl 2","key":"3669_CR47","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1097\/MCG.0000000000000683","volume":"50","author":"T Graziano","year":"2016","unstructured":"Graziano T, Amoruso A, Nicola S, Deidda F, Allesina S, Pane M et al (2016) The possible innovative use of Bifidobacterium longum w11 in association with rifaximin: a new horizon for combined approach? J Clin Gastroenterol 50(Suppl 2):S153\u2013S156","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"3669_CR48","first-page":"259","volume":"65","author":"F Di Pierro","year":"2019","unstructured":"Di Pierro F, Bertuccioli A, Pane M, Ivaldi L (2019) Effects of rifaximin-resistant Bifidobacterium longum W11 in subjects with symptomatic uncomplicated diverticular disease treated with rifaximin. Minerva Gastroenterol Dietol 65(4):259\u2013264","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"Suppl 2","key":"3669_CR49","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1097\/MCG.0000000000000684","volume":"50","author":"E Lahner","year":"2016","unstructured":"Lahner E, Annibale B (2016) Probiotics and diverticular disease: evidence-based? J Clin Gastroenterol 50(Suppl 2):S159\u2013S160","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"3669_CR50","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/19490976.2017.1345414","volume":"8","author":"M Rondanelli","year":"2017","unstructured":"Rondanelli M, Faliva MA, Perna S, Giacosa A, Peroni G, Castellazzi AM (2017) Using probiotics in clinical practice: where are we now? A review of existing meta-analyses. Gut Microbes 8(6):521\u2013543","journal-title":"Gut Microbes"},{"issue":"2","key":"3669_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/1574887113666180402143140","volume":"13","author":"V Ojetti","year":"2018","unstructured":"Ojetti V, Petruzziello C, Cardone S, Saviano L, Migneco A, Santarelli L et al (2018) The use of probiotics in different phases of diverticular disease. Rev Recent Clin Trials 13(2):89\u201396","journal-title":"Rev Recent Clin Trials"},{"key":"3669_CR52","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1097\/MCG.0000000000000641","volume":"50","author":"C Scarpignato","year":"2016","unstructured":"Scarpignato C, Bertele A, Tursi A (2016) Probiotics for the treatment of symptomatic uncomplicated diverticular disease: rationale and current evidence. J Clin Gastroenterol 50:S70\u2013S73","journal-title":"J Clin Gastroenterol"},{"key":"3669_CR53","volume-title":"Designing and conducting health surveys: a comprehensive guide, vol. 3","author":"LA Aday","year":"2006","unstructured":"Aday LA, Cornelius LJ (2006) Designing and conducting health surveys: a comprehensive guide, vol. 3, 3rd edn. Jossey-Bass, San Francisco","edition":"3"},{"key":"3669_CR54","volume-title":"Handbook of health survey methods","author":"TP Johnson","year":"2015","unstructured":"Johnson TP (2015) Handbook of health survey methods, 1st edn. Wiley, Hoboken, New Jersey","edition":"1"},{"issue":"4","key":"3669_CR55","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1504\/IJBHR.2011.043414","volume":"2","author":"R Rosenman","year":"2011","unstructured":"Rosenman R, Tennekoon V, Hill LG (2011) Measuring bias in self-reported data. Int J Behav Healthc Res 2(4):320\u2013332","journal-title":"Int J Behav Healthc Res"},{"issue":"11","key":"3669_CR56","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/ajg.2015.156","volume":"110","author":"SB Menees","year":"2015","unstructured":"Menees SB, Guentner A, Chey SW, Saad R, Chey WD (2015) How do US gastroenterologists use over-the-counter and prescription medications in patients with gastroesophageal reflux and chronic constipation? Am J Gastroenterol 110(11):1516\u20131525","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"3669_CR57","doi-asserted-by":"publisher","first-page":"689","DOI":"10.14309\/ajg.0000000000000558","volume":"115","author":"JE Kurlander","year":"2020","unstructured":"Kurlander JE, Rubenstein JH, Richardson CR, Krein SL, De Vries R, Zikmund-Fisher BJ et al (2020) Physicians\u2019 perceptions of proton pump inhibitor risks and recommendations to discontinue: a national survey. Am J Gastroenterol 115(5):689\u2013696","journal-title":"Am J Gastroenterol"},{"key":"3669_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/CEG.S340929","volume":"16","author":"G Calini","year":"2023","unstructured":"Calini G, Abd El Aziz MA, Paolini L, Abdalla S, Rottoli M, Mari G et al (2023) Symptomatic uncomplicated diverticular disease (SUDD): practical guidance and challenges for clinical management. Clin Exp Gastroenterol 16:29\u201343","journal-title":"Clin Exp Gastroenterol"},{"issue":"4","key":"3669_CR59","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J et al (2011) GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383\u2013394","journal-title":"J Clin Epidemiol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03669-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-024-03669-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03669-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T13:13:59Z","timestamp":1726492439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-024-03669-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,8]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3669"],"URL":"https:\/\/doi.org\/10.1007\/s11739-024-03669-6","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,8]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LG, MB, WM, AC, AG, CL, PUS, PB, FM, RM, SS, and MS: The authors declare that they have no conflict of interest. CS: member of the International Advisory Board and of the Speakers\u2019 Bureau of Alfasigma. RV: received a grant from Alfasigma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement and informed consent"}}]}}